RxDoctor Payments Data

Sam Mathew

Physician Assistant · Dallas, TXNPI 1619198082

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,885 of the $2,618 with a category attached, or 72.0%. 38 manufacturers reported payments, led by Incyte Corporation at 25.3% of the total. Reporting peaked in 2022 at $852 and has fallen 67.5% since, to $277 in 2025.

$2,618in general payments, 2019–2025

Across 96 payments — averaging $27.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$663
  • Astellas Pharma US Inc$478
  • Jazz Pharmaceuticals Inc.$114
  • Janssen Scientific Affairs, LLC$104
  • Amgen$100
  • Acrotech Biopharma Inc.$96
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$1,88572%
  • Education$73428%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,618 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl22$514
Acyclovir33$299
Prochlorperazine Maleate16$150
Ondansetron Hcl15$117
Levofloxacin11$102

Paid to pharmacies, not to this prescriber.

Other physician assistant in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →